SMT201600101B - Uso di agenti sensibilizzanti all’insulina somministrati per via vaginale - Google Patents

Uso di agenti sensibilizzanti all’insulina somministrati per via vaginale

Info

Publication number
SMT201600101B
SMT201600101B SM201600101T SM201600101T SMT201600101B SM T201600101 B SMT201600101 B SM T201600101B SM 201600101 T SM201600101 T SM 201600101T SM 201600101 T SM201600101 T SM 201600101T SM T201600101 B SMT201600101 B SM T201600101B
Authority
SM
San Marino
Prior art keywords
insulin
submitted via
sensitizing agents
via vaginal
vaginal
Prior art date
Application number
SM201600101T
Other languages
English (en)
Inventor
Del Prado Jaime Moscoso
Tosi Beatriz Banfi
Original Assignee
Itf Res Pharma Slu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Itf Res Pharma Slu filed Critical Itf Res Pharma Slu
Publication of SMT201600101B publication Critical patent/SMT201600101B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/655Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SM201600101T 2009-02-18 2016-04-12 Uso di agenti sensibilizzanti all’insulina somministrati per via vaginale SMT201600101B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200900448A ES2344183B1 (es) 2009-02-18 2009-02-18 Uso de agentes sensibilizantes a insulina por via vaginal.
PCT/ES2010/000067 WO2010094821A1 (es) 2009-02-18 2010-02-16 Uso de agentes sensibilizantes a insulina por vía vaginal

Publications (1)

Publication Number Publication Date
SMT201600101B true SMT201600101B (it) 2016-07-01

Family

ID=42537373

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201600101T SMT201600101B (it) 2009-02-18 2016-04-12 Uso di agenti sensibilizzanti all’insulina somministrati per via vaginale

Country Status (13)

Country Link
US (1) US20120004271A1 (it)
EP (1) EP2399583B1 (it)
BR (1) BRPI1005950A2 (it)
CY (1) CY1117425T1 (it)
DK (1) DK2399583T3 (it)
ES (2) ES2344183B1 (it)
HR (1) HRP20160280T1 (it)
HU (1) HUE027369T2 (it)
PL (1) PL2399583T3 (it)
RU (1) RU2567334C2 (it)
SI (1) SI2399583T1 (it)
SM (1) SMT201600101B (it)
WO (1) WO2010094821A1 (it)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US5874454A (en) * 1993-09-15 1999-02-23 Warner-Lambert Company Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus
FR2774591B1 (fr) * 1998-02-12 2000-05-05 Lipha Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
US6100300A (en) * 1998-04-28 2000-08-08 Bristol-Myers Squibb Company Metformin formulations and method for treating intermittent claudication employing same
RU2201225C2 (ru) * 1999-04-06 2003-03-27 Зыкова Татьяна Алексеевна Способ лечения хронической ановуляции и профилактики синдрома гиперстимуляции яичников
US7105489B2 (en) * 2002-01-22 2006-09-12 Amylin Pharmaceuticals, Inc. Methods and compositions for treating polycystic ovary syndrome
WO2003066061A1 (en) * 2002-02-07 2003-08-14 Pfizer Limited Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome
WO2003068209A1 (en) * 2002-02-14 2003-08-21 Sonus Pharmaceuticals, Inc. Metformin salts of lipophilic acids

Also Published As

Publication number Publication date
RU2011135702A (ru) 2013-03-27
ES2569538T3 (es) 2016-05-11
PL2399583T3 (pl) 2016-09-30
WO2010094821A1 (es) 2010-08-26
CY1117425T1 (el) 2017-04-26
ES2344183B1 (es) 2011-06-10
US20120004271A1 (en) 2012-01-05
RU2567334C2 (ru) 2015-11-10
ES2344183A1 (es) 2010-08-19
BRPI1005950A2 (pt) 2016-02-10
EP2399583A1 (en) 2011-12-28
HUE027369T2 (hu) 2016-09-28
DK2399583T3 (en) 2016-04-18
EP2399583B1 (en) 2016-01-27
SI2399583T1 (sl) 2016-06-30
EP2399583A4 (en) 2012-08-15
HRP20160280T1 (hr) 2016-06-17

Similar Documents

Publication Publication Date Title
SMT201600222B (it) Formulazione di anticorpi
SMT201600075B (it) Composto di diamminocarbossammide eterociclica
BRPI0917535A2 (pt) uso de insulina de ação ultra rápida
CO6870033A2 (es) Compuestos terapéuticos y métodos de uso relacionados
SMT201400008B (it) Uso di betanecolo per il trattamento di xerostomia
RU2557654C3 (ru) Терапевтические агенты для снижения уровней паратиреоидного гормона
FR2956314B1 (fr) Orthese compressive tubulaire
BRPI0807487A2 (pt) Uso de antagonistas de il-23 para o tratamento de infecção
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
SMT201700064B (it) Antagonisti di d2, metodi di sintesi e metodi di uso
DK2242409T3 (da) Engangspumpe med tilbagesugningsmekanisme
BRPI1005670A2 (pt) composições adjuvantes e métodos de uso
BRPI0913833A2 (pt) uso de corantes ácidos
BRPI1009442A2 (pt) uso de lactóis rosuvastatina como medicamentos
IT1400741B1 (it) Dispositivo per preparare carburo di silicio monocristallo
FI20105639A0 (fi) Mikroselluloosan valmistus
SMT201300067B (it) Applicazioni terapeutiche di derivati di chinazolindione
BRPI1011036A2 (pt) uso
SMT201600054B (it) Uso di composti di 1h-indazolo-3-carbossammide come inibitori della glicogeno sintasi chinasi 3 beta
BR112012031861A2 (pt) uso de 5a-androstano (alquil)-3b, 5, 6b-triol
BRPI1013597A2 (pt) seringa para uso único
FI20096402A0 (fi) Veriryhmästatuksen käyttö II
BRPI0909840A2 (pt) Uso de 4-tio-2-deoxinucleosídios
BRPI0914941A2 (pt) preparação de inibidores de incrustação ambientalmente aceitáveis
BR112013013551A2 (pt) composto e uso médico do mesmo